WITHDRAWAL OF LOW-DOSE STEROIDS IN SYSTEMIC LUPUS ERYTHEMATOSUS IN REMISSION: PREDICTORS OF FLARES AND DIFFERENCE IN OUTCOMES IN SEROLOGICALLY ACTIVE CLINICALLY QUIESCENT PATIENTS

被引：2
|
作者：
Fasano, S. [1 ]
Pierro, L. [1 ]
Coscia, M. A. [1 ]
Bucci, L. [1 ]
Scriffignano, S. [1 ]
Riccardi, A. [1 ]
Ciccia, F. [1 ]
机构：
[1] Univ Campania Luigi Vanvitelli, Rheumatol, Naples, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
CLASSIFICATION;
D O I：
10.1136/annrheumdis-2020-eular.1691
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0162
引用
下载
收藏
页码：1017 / 1018
页数：2
相关论文
共 50 条
  • [41] Which patients with systemic lupus erythematosus in remission can withdraw low dose steroids? Results from a single inception cohort study
    Fasano, Serena
    Coscia, Melania Alessia
    Pierro, Luciana
    Ciccia, Francesco
    LUPUS, 2021, 30 (06) : 991 - 997
  • [42] Water intoxication induced by low-dose cyclophosphamide in two patients with systemic lupus erythematosus
    Salido, M
    Macarron, P
    Hernández-García, C
    D'Cruz, DP
    Khamashta, MA
    Hughes, GRV
    LUPUS, 2003, 12 (08) : 636 - 639
  • [43] EFFICACY AND SAFETY OF LOW-DOSE IL-2 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Su, Q. Y.
    Luo, J.
    Di, J. K.
    Yin, X. Y.
    Xu, D. N.
    Li, X.
    Wang, C.
    Zhang, S. X.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 640 - 641
  • [44] The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus
    Weng, Meng-Yu
    Weng, Chia-Tse
    Liu, Ming-Fei
    CLINICAL RHEUMATOLOGY, 2010, 29 (07) : 771 - 775
  • [45] The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus
    Meng-Yu Weng
    Chia-Tse Weng
    Ming-Fei Liu
    Clinical Rheumatology, 2010, 29 : 771 - 775
  • [46] The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus - Findings of a prospective, randomized, double-blind, placebo-controlled trial
    Tseng, Chung-E
    Buyon, Jill P.
    Kim, Mimi
    Belmont, H. Michael
    Mackay, Meggan
    Diamond, Betty
    Marder, Galina
    Rosenthal, Pamela
    Haines, Kathleen
    Ilie, Virginia
    Abramson, Steven B.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (11): : 3623 - 3632
  • [47] Low-Dose IL-2 Combined with Rapamycin Efficiently Promotes Remission of Refractory Systemic Lupus Erythematosus
    Liang, Zhaoyun
    Jing, Xiaona
    Hao, Meihua
    Gao, Chong
    Li, Xiao-Feng
    Chen, Junwei
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [48] Frequencies and predictors of the Lupus Low Disease Activity State and remission in treatment-naive patients with systemic lupus erythematosus
    Gao, Dai
    Hao, Yanjie
    Mu, Lin
    Xie, Wenhui
    Fan, Yong
    Ji, Lanlan
    Zhang, Zhuoli
    RHEUMATOLOGY, 2020, 59 (11) : 3400 - 3407
  • [49] EFFECT OF GENETIC POLYMORHISMS ON THE EFFICACY OF LOW-DOSE AZATHIOPRINE THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Aomori, T.
    Nagamine, A.
    Takenaka, M.
    Okada, Y.
    Hiromura, K.
    Nojima, Y.
    Araki, T.
    Nakamura, T.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 67 - 67
  • [50] Effect of genetic polymorphisms on effectiveness of low-dose azathioprine in Japanese patients with systemic lupus erythematosus
    Nagamine, Ayumu
    Takenaka, Miki
    Aomori, Tohru
    Okada, Yuko
    Hiromura, Keiju
    Nojima, Yoshihisa
    Araki, Takuya
    Nakamura, Tomonori
    Yamamoto, Koujirou
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (23) : 2072 - 2078
12345